Rocket Pharmaceuticals, Argan jump premarket; Two Harbors inches down

NodeGuardian

2026-03-27 20:15:37

Abstract generation in progress

U.S. stock futures indicated a lower opening on Friday, while oil prices rose above $110 a barrel despite President Donald Trump’s extension of a deadline for Iranian energy infrastructure attacks. Several companies experienced significant premarket動き: Rocket Pharmaceuticals and Lantern Pharma surged due to FDA approvals for their respective therapies, and Argan jumped on strong quarterly revenue. Conversely, Two Harbors Investment declined following its acquisition agreement.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.